Design, synthesis, in vitro and in vivo evaluation of benzylpiperidine-linked 1,3-dimethylbenzimidazolinones as cholinesterase inhibitors against Alzheimer’s disease

References

• Suh YH, Checler F. Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer’s disease. Pharmacol Rev 2002;54:469–525.
   PubMed Web of Science ®Google Scholar
• Tumiatti V, Minarini A, Bolognesi ML, et al. Tacrine derivatives and Alzheimer’s disease. Curr Med Chem 2010;17:1825–38.
   PubMed Web of Science ®Google Scholar
• Mendiola-Precoma J, Berumen LC, Padilla K, Garcia-Alcocer G. Therapies for prevention and treatment of Alzheimer’s disease. Biomed Res Int 2016;2016:2589276.
   PubMed Web of Science ®Google Scholar
• Prince M, Wimo A, Guerchet M, et al. World Alzheimer Report 2018. The global impact of dementia. An analysis of prevalence, incidence, cost and trends. London: Alzheimer’s Disease International; 2018.
   Google Scholar
• Shidore M, Machhi J, Shingala K, et al. Benzylpiperidine-linked diarylthiazoles as potential anti-Alzheimer’s agents: synthesis and biological evaluation. J Med Chem 2016;59:5823–46.
   PubMed Web of Science ®Google Scholar
• Goedert M, Spillantini MG. A century of Alzheimer’s disease. Science 2006;314:777–81.
   PubMed Web of Science ®Google Scholar
• Cavalli A, Bolognesi ML, Minarini A, et al. Multi-target-directed ligands to combat neurodegenerative diseases. J Med Chem 2008;51:347–72.
   PubMed Web of Science ®Google Scholar
• Kumar A, Singh A, Ekavali   A review on Alzheimer’s disease pathophysiology and its management: an update. Pharmacol Rep 2015;67:195–203.
   PubMed Web of Science ®Google Scholar
• Berk C, Paul G, Sabbagh M. Investigational drugs in Alzheimer’s disease: current progress. Expert Opin Inv Drug 2014;23:837–46.
   PubMed Web of Science ®Google Scholar
• Gocer H, Akincioglu A, Goksu S, et al. Carbonic anhydrase and acetylcholinesterase inhibitory effects of carbamates and sulfamoylcarbamates. J Enzym Inhib Med Ch 2015;30:316–20.
   PubMed Web of Science ®Google Scholar
• Ferreira-Vieira TH, Guimaraes IM, Silva FR, Ribeiro FM. Alzheimer’s disease: targeting the cholinergic system. Curr Neuropharmacol 2016;14:101–15.
   PubMed Web of Science ®Google Scholar
• Xie SS, Wang XB, Li JY, et al. Design, synthesis and evaluation of novel tacrine coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer’s disease. Eur J Med Chem 2013;64:540–53.
   PubMed Web of Science ®Google Scholar
• Hosoi M, Hori K, Konishi K, et al. Plasma cholinesterase activity in Alzheimer’s disease. Neurodegener Dis 2015;15:188–90.
   PubMed Web of Science ®Google Scholar
• Ismaili L, Refouvelet B, Benchekroun M, et al. Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer’s disease. Prog Neurobiol 2017;151:4–34.
   PubMed Web of Science ®Google Scholar
• Li GL, Hong G, Li XY, et al. Synthesis and activity towards Alzheimer’s disease in vitro: tacrine, phenolic acid and ligustrazine hybrids. Eur J Med Chem 2018;148:238–54.
   PubMed Web of Science ®Google Scholar
• Mesulam M, Guillozet A, Shaw P, Quinn B. Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain. Neurobiol Dis 2002;9:88–93.
   PubMed Web of Science ®Google Scholar
• Li Q, He SY, Chen Y, et al. Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer’s disease. Eur J Med Chem 2018;158:463–77.
   PubMed Web of Science ®Google Scholar
• Mesulam MM, Guillozet A, Shaw P, et al. Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience 2002;110:627–39.
   PubMed Web of Science ®Google Scholar
• El-Sayed NA, Farag AE, Ezzat MAF, et al. Design, synthesis, in vitro and in vivo evaluation of novel pyrrolizine-based compounds with potential activity as cholinesterase inhibitors and anti-Alzheimer’s agents. Bioorg Chem 2019;93:103312.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Sun W, Peng J, et al. Design, synthesis and biological evaluation of novel copper-chelating acetylcholinesterase inhibitors with pyridine and N-benzylpiperidine fragments. Bioorg Chem 2019;93:103322.
   PubMed Web of Science ®Google Scholar
• Mo J, Yang H, Chen T, et al. Design, synthesis, biological evaluation, and molecular modeling studies of quinoline-ferulic acid hybrids as cholinesterase inhibitors. Bioorg Chem 2019;93:103310.
   PubMed Web of Science ®Google Scholar
• Chen Y, Lin HZ, Yang HY, et al. Discovery of new acetylcholinesterase and butyrylcholinesterase inhibitors through structure-based virtual screening. Rsc Adv 2017;7:3429–38.
   Web of Science ®Google Scholar
• Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95.
   PubMed Web of Science ®Google Scholar
• Tamagno E, Bardini P, Obbili A, et al. Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol Dis 2002;10:279–88.
   PubMed Web of Science ®Google Scholar
• Zhu J, Yang HY, Chen Y, et al. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer’s disease. J Enzym Inhib Med Ch 2018;33:496–506.
   PubMed Web of Science ®Google Scholar
• Lefebvre CA, Forcellini E, Boutin S, et al. Synthesis of novel substituted pyrimidine derivatives bearing a sulfamide group and their in vitro cancer growth inhibition activity. Bioorg Med Chem Lett 2017;27:299–302.
   PubMed Web of Science ®Google Scholar
• Bronner SM, Murray J, Romero FA, et al. A Unique Approach to Design Potent and Selective Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP) Inhibitors. J Med Chem 2017;60:10151–71.
   PubMedGoogle Scholar
• Xu YL, Lin HY, Ruan X, et al. Synthesis and bioevaluation of pyrazole-benzimidazolone hybrids as novel human 4-Hydroxyphenylpyruvate dioxygenase inhibitors. Eur J Med Chem 2015;92:427–38.
   PubMed Web of Science ®Google Scholar
• Lin SY, Yeh TK, Kuo CC, et al. Phenyl Benzenesulfonylhydrazides Exhibit Selective Indoleamine 2,3-Dioxygenase Inhibition with Potent in Vivo Pharmacodynamic Activity and Antitumor Efficacy. J Med Chem 2016;59:419–30.
   PubMed Web of Science ®Google Scholar
• Xu LL, Zhang X, Jiang ZY, You QD. Molecular similarity guided optimization of novel Nrf2 activators with 1,2,4-oxadiazole core. Bioorgan Med Chem 2016;24:3540–7.
   PubMed Web of Science ®Google Scholar